{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:32:42Z","timestamp":1792783962493,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Justice Health and Forensic Mental Health Network"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.drugpo.2019.02.013","type":"journal-article","created":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T07:17:20Z","timestamp":1554535040000},"page":"123-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6726-5722","authenticated-orcid":false,"given":"Kristen","family":"Overton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Clegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Pekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.drugpo.2019.02.013_bib0005","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/jvh.12580","article-title":"A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy","volume":"23","author":"Aspinall","year":"2016","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0010","series-title":"Fourth national hepatitis C strategy 2014\u20132017","author":"Australian Government Department of Health","year":"2014"},{"issue":"3","key":"10.1016\/j.drugpo.2019.02.013_bib0015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/cid\/ciy210","article-title":"Demonstration of near-elimination of hepatitis C virus among a prison population: The Lotus Glen Correctional Centre hepatitis C treatment project","volume":"67","author":"Bartlett","year":"2018","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1016\/j.drugpo.2019.02.013_bib0020","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5694\/mja17.01077","article-title":"Eradicating hepatitis C from the New South Wales prison system","volume":"208","author":"Blogg","year":"2018","journal-title":"The Medical Journal of Australia"},{"issue":"9","key":"10.1016\/j.drugpo.2019.02.013_bib0025","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5694\/j.1326-5377.2010.tb03605.x","article-title":"Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C","volume":"192","author":"Boonwaat","year":"2010","journal-title":"The Medical Journal of Australia"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0030","series-title":"National prison entrants\u2019 bloodborne virus survey report 2004, 2007, 2010, 2013 and 2016","author":"Butler","year":"2017"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0035","series-title":"NSW inmate census 2016: Summary of characteristics","author":"Corben","year":"2017"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0040","doi-asserted-by":"crossref","DOI":"10.1038\/s41395-018-0157-x","article-title":"Microenvironment eradication of hepatitis C: A novel treatment paradigm","author":"Cuadrado","year":"2018","journal-title":"The American Journal of Gastroenterology"},{"issue":"5","key":"10.1016\/j.drugpo.2019.02.013_bib0045","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nrgastro.2013.17","article-title":"Future therapies for chronic hepatitis C","volume":"10","author":"Dabbouseh","year":"2013","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"10049","key":"10.1016\/j.drugpo.2019.02.013_bib0050","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","article-title":"Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees","volume":"388","author":"Dolan","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0055","doi-asserted-by":"crossref","unstructured":"EASL Recommendations on Treatment of Hepatitis C 2018 (2018). Journal of Hepatology, 69(2), 461-511 10.1016\/j.jhep.2018.03.026.","DOI":"10.1016\/j.jhep.2018.03.026"},{"issue":"4 Pt 1","key":"10.1016\/j.drugpo.2019.02.013_bib0060","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/jhep.2001.27831","article-title":"Estimating progression to cirrhosis in chronic hepatitis C virus infection","volume":"34","author":"Freeman","year":"2001","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.drugpo.2019.02.013_bib0065","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1440-1746.2009.05910.x","article-title":"The epidemiology of hepatitis C in Australia: Notifications, treatment uptake and liver transplantations, 1997-2006","volume":"24","author":"Gidding","year":"2009","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"1 Suppl","key":"10.1016\/j.drugpo.2019.02.013_bib0070","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"Journal of Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.drugpo.2019.02.013_bib0075","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/infdis\/jis928","article-title":"Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV\/HIV coinfection: action required at the system, provider, and patient levels","volume":"207","author":"Grebely","year":"2013","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0080","unstructured":"Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. (2018). Geneva."},{"issue":"11","key":"10.1016\/j.drugpo.2019.02.013_bib0085","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/jvh.12943","article-title":"Real-world outcomes of unrestricted direct-acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience","volume":"25","author":"Haridy","year":"2018","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0090","doi-asserted-by":"crossref","unstructured":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. (2015). Hepatology, 62(3), 932-954 10.1002\/hep.27950.","DOI":"10.1002\/hep.27950"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0095","series-title":"Australian recommendations for the management of hepatitis C virus infection: A consensus statement (March 2016)","author":"Hepatitis C Virus Infection Consensus Statement Working Group","year":"2016"},{"issue":"1","key":"10.1016\/j.drugpo.2019.02.013_bib0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40352-017-0055-0","article-title":"The continuum of hepatitis C care for criminal justice involved adults in the DAA era: A retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based care","volume":"5","author":"Hochstatter","year":"2017","journal-title":"Health & Justice"},{"issue":"4","key":"10.1016\/j.drugpo.2019.02.013_bib0105","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ajg.2008.143","article-title":"Viral hepatitis in incarcerated adults: A medical and public health concern","volume":"104","author":"Hunt","year":"2009","journal-title":"The American Journal of Gastroenterology"},{"issue":"5","key":"10.1016\/j.drugpo.2019.02.013_bib0110","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/M17-0118","article-title":"Expansion of treatment for hepatitis C virus infection by task shifting to community-based nonspecialist providers: A nonrandomized clinical trial","volume":"167","author":"Kattakuzhy","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/j.drugpo.2019.02.013_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192763","article-title":"Capacity of non-invasive hepatic fibrosis algorithms to replace transient elastography to exclude cirrhosis in people with hepatitis C virus infection: A multi-centre observational study","volume":"13","author":"Kelly","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.drugpo.2019.02.013_bib0120","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5009\/gnl14083","article-title":"Emerging therapies for hepatitis C","volume":"8","author":"Kim","year":"2014","journal-title":"Gut and Liver"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugpo.2018.04.003","article-title":"Interventions to increase testing, linkage to care and treatment of hepatitis C virus (HCV) infection among people in prisons: A systematic review","volume":"57","author":"Kronfli","year":"2018","journal-title":"The International Journal of Drug Policy"},{"issue":"October (4)","key":"10.1016\/j.drugpo.2019.02.013_bib0130","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.26387","article-title":"Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis","volume":"58","author":"Larney","year":"2013","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.drugpo.2019.02.013_bib0135","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/cid\/cis1202","article-title":"Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting","volume":"56","author":"Lloyd","year":"2013","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0140","series-title":"VassarStats: Website for statistical computation","author":"Lowry","year":"2019"},{"issue":"1","key":"10.1016\/j.drugpo.2019.02.013_bib0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1108\/IJPH-08-2015-0025","article-title":"Hepatitis C in Australian prisons: A national needs assessment","volume":"12","author":"Mina","year":"2016","journal-title":"International Journal of Prisoner Health"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0150","article-title":"Increased diagnosis and treatment of hepatitis C in prison by universal offer of testing and use of telemedicine","author":"Morey","year":"2018","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2019.01.012","article-title":"Outcomes of treatment for hepatitis C in prisoners using a nurse-led, state-wide model of care","author":"Papaluca","year":"2019","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0160","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.drugpo.2018.06.017","article-title":"Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy","volume":"59","author":"Pontali","year":"2018","journal-title":"The International Journal of Drug Policy"},{"issue":"Suppl 2","key":"10.1016\/j.drugpo.2019.02.013_bib0165","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1093\/cid\/cit265","article-title":"Enhancing assessment and treatment of hepatitis C in the custodial setting","volume":"57","author":"Post","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"7","key":"10.1016\/j.drugpo.2019.02.013_bib0170","doi-asserted-by":"crossref","first-page":"464","DOI":"10.5694\/mja13.10925","article-title":"Treatment outcomes for indigenous and non-Indigenous inmates with hepatitis C in New South Wales prisons","volume":"199","author":"Post","year":"2013","journal-title":"The Medical Journal of Australia"},{"issue":"20","key":"10.1016\/j.drugpo.2019.02.013_bib0175","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1056\/NEJMp1311941","article-title":"Responding to hepatitis C through the criminal justice system","volume":"370","author":"Rich","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.drugpo.2019.02.013_bib0180","first-page":"27","article-title":"Impact of new therapeutics for hepatitis C virus infection in incarcerated populations","volume":"21","author":"Spaulding","year":"2013","journal-title":"Topics in Antiviral Medicine"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0185","series-title":"Monitoring hepatitis C treatment uptake in Australia (Issue 9)","author":"The Kirby Institute","year":"2018"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0190","series-title":"HIV, viral hepatitis and sexually transmissible infections in Australia: Annual surveillance report 2017","author":"The Kirby Institute","year":"2017"},{"key":"10.1016\/j.drugpo.2019.02.013_bib0195","series-title":"Initiations of new treatment for chronic hepatitis C in 2016","author":"The Kirby Institute","year":"2017"},{"issue":"2","key":"10.1016\/j.drugpo.2019.02.013_bib0200","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5694\/mja17.00323","article-title":"Hepatitis C in Australia\u2014A role for general practitioners?","volume":"207","author":"van Driel","year":"2017","journal-title":"The Medical Journal of Australia"},{"issue":"12","key":"10.1016\/j.drugpo.2019.02.013_bib0205","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/jvh.12998","article-title":"A systematic review on models of care effectiveness and barriers to hepatitis C treatment in prison settings in the EU\/EEA","volume":"25","author":"Vroling","year":"2018","journal-title":"Journal of Viral Hepatitis"},{"issue":"1 Suppl","key":"10.1016\/j.drugpo.2019.02.013_bib0210","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"Journal of Hepatology"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395919300787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395919300787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:43:42Z","timestamp":1760629422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395919300787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":42,"alternative-id":["S0955395919300787"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2019.02.013","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2019.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}